A few years back, there was a BP that was exploring the use of Brilacidin as an anti-microbial coating for implants. As I recall, it got to the point that they needed B to make it through a particular level of testing? If anyone has that information handy, I would be interesting in refreshing my knowledge on this topic. I remember J&J being mentioned as the BP but I don’t remember whether that was a deduction based on a particular piece of information or just speculation. I don’t think that the BP was specifically identified by the company.
